Skip to main content
Top
Published in: Journal of Endocrinological Investigation 9/2015

01-09-2015 | Endocrinology and Art

The acromegalic voice of Tango: Don Edmundo Rivero

Authors: H. Valdes-Socin, W. W. De Herder, A. Beckers

Published in: Journal of Endocrinological Investigation | Issue 9/2015

Login to get access

Excerpt

Leonel Edmundo Rivero (June 8, 1911–January 18, 1986) was a one of the most famous Argentinean tango singers of the second half of the twentieth century (Fig. 1). A deep bass-baritone voice was his trademark [1], whereas most tango singers used to be tenors. Don Edmundo Rivero had huge hands and feet, as demonstrated on the photographs (Figs. 1,  2). He also had other symptoms which are typical of acromegaly like marked prognathism, diastema, and visible nasolabial folds. According to Argentinean endocrinologist Dr Guitelman, he received treatment for acromegaly [2].
Metadata
Title
The acromegalic voice of Tango: Don Edmundo Rivero
Authors
H. Valdes-Socin
W. W. De Herder
A. Beckers
Publication date
01-09-2015
Publisher
Springer International Publishing
Published in
Journal of Endocrinological Investigation / Issue 9/2015
Electronic ISSN: 1720-8386
DOI
https://doi.org/10.1007/s40618-015-0350-3

Other articles of this Issue 9/2015

Journal of Endocrinological Investigation 9/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine